Diagnosis and Management of Drug-Induced Interstitial Lung Disease Associated with Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium Avium Complex Pulmonary Disease: A Case Report

Diagnosis and Management of Drug-Induced Interstitial Lung Disease Associated with Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium Avium Complex Pulmonary Disease: A Case Report

Kazuki Hashimoto, Takuro Nii, Hitoshi Sumitani, Masashi Yokoyama, Satoshi Miyamoto, Yasuhiro Mihashi, Yuka Nagata, Takanori Matsuki, Kazuyuki Tsujino, Keisuke Miki, Hiroshi Kida Department of Respiratory Medicine, National Hospital Organization Osaka Toneyama Medical Center, Osaka, JapanCorresponden...

Full description

Bibliographic Details
Main Authors: Hashimoto K, Nii T, Sumitani H, Yokoyama M, Miyamoto S, Mihashi Y, Nagata Y, Matsuki T, Tsujino K, Miki K, Kida H
Format: Article
Language:English
Published: Dove Medical Press 2023-10-01
Series:Infection and Drug Resistance
Subjects:
amikacin liposome inhalation suspension mycobacterium avium complex pulmonary disease drug-induced interstitial lung disease drug provocation test paradoxical response
Online Access:https://www.dovepress.com/diagnosis-and-management-of-drug-induced-interstitial-lung-disease-ass-peer-reviewed-fulltext-article-IDR

Internet

https://www.dovepress.com/diagnosis-and-management-of-drug-induced-interstitial-lung-disease-ass-peer-reviewed-fulltext-article-IDR

Similar Items